Retractable Technologies Inc (RVP)
0.7972
+0.06
(+8.55%)
USD |
NYAM |
Jan 03, 16:00
0.7936
0.00 (0.00%)
After-Hours: 20:00
Retractable Technologies SG&A Expense (Quarterly): 4.946M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
Plus Therapeutics Inc | 2.397M |
Perspective Therapeutics Inc | 6.975M |
InfuSystems Holdings Inc | 15.53M |
Xtant Medical Holdings Inc | 19.38M |
Catheter Precision Inc | 2.882M |